
Regulation drives investor shift back to crop genetics, says Resurrect Bio CEO
Easing gene-editing regulations are driving interest towards crop genetics and disease resistance, according to Resurrect Bio CEO Cian Duggan, who says corporate investors are playing an increasingly important role in supporting innovation across the sector

